Transgene Biotek Limited
BSE: TRABI
Prev Close
4.79
Open Price
5.1
Volume
167,359
Today Low / High
4.32 / 5.1
52 WK Low / High
3.22 / 7.71
Range
4 - 5
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 4.32, reflecting a change of -0.47 (-9.81211%). The expected target range on the BSE is 4 - 5. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Transgene Biotek Limited Graph
Transgene Biotek Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Transgene Biotek Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 4.32, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 4.32 | 4.36 | 3.93 - 4.80 |
| 4.41 | 3.53 - 5.29 | ||
| 4.45 | 3.11 - 5.78 | ||
| Bearish Scenario | 4.32 | 4.28 | 3.85 - 4.70 |
| 4.23 | 3.39 - 5.08 | ||
| 4.19 | 2.93 - 5.45 |
Overview of Transgene Biotek Limited
ISIN
INE773D01018
Industry
Biotechnology
Vol.Avg
22,796
Market Cap
311,749,795
Last Dividend
0
Official Website
IPO Date
2001-12-31
DCF Diff
6.30
DCF
-2
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.26 Cr | 1.48 Cr | 0.26 Cr | 1.0000 | 0.00 Cr | 0.00 Cr | -0.05 Cr | -0.68 Cr | -0.09 | -1.12 Cr | -2.5934 |
| 2024-03-31 | 0.23 Cr | 0.40 Cr | -0.17 Cr | -0.7203 | 0.00 Cr | 0.35 Cr | -0.71 Cr | -0.66 Cr | -0.09 | -0.43 Cr | -2.7905 |
| 2023-03-31 | 0.06 Cr | 0.07 Cr | -0.01 Cr | -0.2039 | 4.85 Cr | 0.12 Cr | -6.00 Cr | -6.01 Cr | -0.79 | -0.88 Cr | -109.0793 |
| 2022-03-31 | 0.09 Cr | -0.05 Cr | 0.13 Cr | 1.5331 | 0.00 Cr | 0.11 Cr | -10.39 Cr | -10.40 Cr | -1.37 | -0.25 Cr | -119.9840 |
| 2021-03-31 | 0.17 Cr | 0.06 Cr | 0.11 Cr | 0.6412 | 0.00 Cr | 0.17 Cr | -10.44 Cr | -10.43 Cr | -1.38 | -0.26 Cr | -61.5434 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.28 Cr | 144.09 Cr | 134.06 Cr | 10.0299 Cr | 14.52 Cr | 14.24 Cr | 0.03 Cr | 3.29 Cr | 0.00 Cr | 0.00 Cr | 0.10 Cr | 12.7375 Cr |
| 2024-03-31 | 0.01 Cr | 142.33 Cr | 131.62 Cr | -6.8709 Cr | 14.00 Cr | 13.99 Cr | 0.03 Cr | 1.67 Cr | 0.00 Cr | 0.18 Cr | 0.10 Cr | 11.0358 Cr |
| 2023-03-31 | 0.00 Cr | 142.36 Cr | 130.99 Cr | 11.3688 Cr | 13.11 Cr | 13.11 Cr | 0.03 Cr | 1.76 Cr | 0.10 Cr | 0.35 Cr | 133.00 Cr | 10.4669 Cr |
| 2022-03-31 | 0.01 Cr | 147.10 Cr | 129.72 Cr | 17.3774 Cr | 12.01 Cr | 12.00 Cr | 0.09 Cr | 1.85 Cr | 0.16 Cr | 0.53 Cr | 133.00 Cr | 9.2064 Cr |
| 2021-03-31 | 0.01 Cr | 156.88 Cr | 134.64 Cr | 22.2391 Cr | 11.33 Cr | 11.32 Cr | 0.02 Cr | 2.03 Cr | 7.13 Cr | 0.70 Cr | 132.90 Cr | 14.1780 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.1958 Cr | -1.6995 Cr | 0.7803 Cr | -0.5037 Cr | 0.2766 Cr | 0.2843 Cr | -1.6995 Cr | -0.6761 Cr | 1.0234 Cr | 0.0000 Cr | -0.0001 Cr |
| 2024-03-31 | 0.0046 Cr | 0.0000 Cr | 0.0000 Cr | 0.0046 Cr | 0.0046 Cr | 0.0077 Cr | 0.0000 Cr | -0.6555 Cr | 0.7521 Cr | 0.0000 Cr | -0.0001 Cr |
| 2023-03-31 | 0.0002 Cr | -0.0123 Cr | 0.8511 Cr | -0.0012 Cr | -0.0121 Cr | 0.0031 Cr | -0.0015 Cr | -6.0084 Cr | 0.8511 Cr | 0.0000 Cr | 0.0609 Cr |
| 2022-03-31 | 0.0978 Cr | -0.0969 Cr | 0.4588 Cr | 0.0960 Cr | 0.0009 Cr | 0.0151 Cr | -0.0018 Cr | -10.4020 Cr | 0.4588 Cr | 0.0000 Cr | -0.0741 Cr |
| 2021-03-31 | 0.0126 Cr | -0.0274 Cr | 0.0000 Cr | -0.0148 Cr | -0.0148 Cr | 0.0242 Cr | -0.0274 Cr | -10.4347 Cr | 0.0000 Cr | 0.0000 Cr | 0.0179 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.08 Cr | 0.09 Cr | 0.08 Cr | 1.0000 | 0.01 Cr | -0.71 Cr | -0.09 | -0.54 Cr | -9.3216 |
| 2024-12-31 | 0.08 Cr | 0.00 Cr | 0.08 Cr | 1.0000 | -0.12 Cr | -0.09 Cr | -0.01 | -0.05 Cr | -1.1634 |
| 2024-09-30 | 0.06 Cr | 0.00 Cr | 0.06 Cr | 1.0000 | -0.10 Cr | -0.07 Cr | -0.01 | -0.03 Cr | -1.2547 |
| 2024-06-30 | 0.05 Cr | 0.00 Cr | 0.05 Cr | 1.0000 | -0.44 Cr | 0.20 Cr | 0.03 | 0.24 Cr | 4.0528 |
| 2024-03-31 | 0.05 Cr | 0.10 Cr | -0.06 Cr | -1.2222 | -0.29 Cr | -0.27 Cr | -0.04 | -0.22 Cr | -6.0511 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.28 Cr | 0.00 Cr | 0.28 Cr | 0.01 Cr | 0.03 Cr | 1.26 Cr | 3.29 Cr | 144.09 Cr | 134.06 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -10.83 Cr |
| 2024-09-30 | 0.01 Cr | 0.00 Cr | 0.01 Cr | 0.00 Cr | 0.03 Cr | 0.89 Cr | 1.63 Cr | 142.07 Cr | 131.23 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -10.71 Cr |
| 2024-03-31 | 0.01 Cr | 0.00 Cr | 0.01 Cr | 0.01 Cr | 0.03 Cr | 1.11 Cr | 1.67 Cr | 142.33 Cr | 131.62 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.71 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -0.07 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -0.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Biotechnology
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Biocon Limited | BIOCON | ₹360.25 | ₹481,639,840,000.00 | ₹2,377,375.00 |
| Syngene International Limited | SYNGENE | ₹659.15 | ₹264,559,669,880.00 | ₹531,474.00 |
| Piramal Pharma Limited | PPLPHARMA | ₹192.13 | ₹255,388,456,666.00 | ₹2,518,788.00 |
| Concord Biotech Limited | CONCORDBIO | ₹1,633.60 | ₹170,901,024,320.00 | ₹64,779.00 |
| Blue Jet Healthcare Limited | BLUEJET | ₹791.75 | ₹137,341,246,285.00 | ₹618,017.00 |
| Jubilant Ingrevia Limited | JUBLINGREA | ₹698.20 | ₹111,209,994,200.00 | ₹170,522.00 |
| Supriya Lifescience Limited | SUPRIYA | ₹656.00 | ₹52,796,716,800.00 | ₹99,003.00 |
| Dishman Carbogen Amcis Limited | DCAL | ₹254.90 | ₹39,963,986,700.00 | ₹44,875.00 |
| Zota Health Care Limited | ZOTA | ₹1,339.30 | ₹39,460,465,550.00 | ₹193,378.00 |
| Panacea Biotec Limited | PANACEABIO | ₹430.65 | ₹26,377,613,955.00 | ₹150,143.00 |
Key Executives
Gender: female
Year Born:
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1942
FAQs about Transgene Biotek Limited
The CEO is Koteswara Rao Kanuru.
The current price is ₹4.74.
The range is ₹3.22-7.71.
The market capitalization is ₹31.17 crores.
The P/E ratio is -53.12.
The company operates in the Healthcare sector.
Overview of Transgene Biotek Limited (ISIN: INE773D01018) is a leading Biotechnology in India. With a market capitalization of ₹31.17 crores and an average daily volume of 22,796 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.